The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.

about

Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.

P2860

Q33557905-415E449F-909B-41A7-93D8-98B74FB656A5 Q53692985-4957F321-95F3-415A-911F-BF8285609A73

P2860

The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.

Item

http://www.wikidata.org/entity/Q53607051

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The Clinicopathologic Features ...... with Resected Gastric Cancer.

@en

The Clinicopathologic Features ...... with Resected Gastric Cancer.

@nl

type

Item

label

The Clinicopathologic Features ...... with Resected Gastric Cancer.

@en

The Clinicopathologic Features ...... with Resected Gastric Cancer.

@nl

prefLabel

The Clinicopathologic Features ...... with Resected Gastric Cancer.

@en

The Clinicopathologic Features ...... with Resected Gastric Cancer.

@nl

P1476

The Clinicopathologic Features ...... with Resected Gastric Cancer.

@en

P2093

Chan Kim

http://www.w3.org/2001/XMLSchema#string

Hye Ryun Kim

http://www.w3.org/2001/XMLSchema#string

Jin Kyu Park

http://www.w3.org/2001/XMLSchema#string

P2860

Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

Molecular classification of gastric cancer: a new paradigm.

Epidemiology of gastric cancer.

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

P2888

s10434-015-4376-8

P304

3938-3945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-015-4376-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272844364

http://www.w3.org/2001/XMLSchema#string

P6179

1046669300

http://www.w3.org/2001/XMLSchema#string

P698

25707491

http://www.w3.org/2001/XMLSchema#string

The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.

about

P2860

P2860

The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698